OHSU Vaccine and Gene Therapy Institute (VGTI)
United States of America (USA)
1 July 2019 - 30 June 2020
Principal institution: Oregon Health and Science University (OHSU)
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for OHSU Vaccine and Gene Therapy Institute (VGTI) published between 1 July 2019 - 30 June 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 8 | 1.27 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 8 | 1.27 | |
Top articles by Altmetric score in current window
Risk of Zika microcephaly correlates with features of maternal antibodies
Journal of Experimental Medicine
2019-10-07
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge
Science Translational Medicine
2019-07-17
Enhancing safety of cytomegalovirus-based vaccine vectors by engaging host intrinsic immunity
Science Translational Medicine
2019-07-17
Innate immunity limits protective adaptive immune responses against pre-erythrocytic malaria parasites
Nature Communications
2019-09-02
The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections
Cell Host & Microbe
2019-07-10
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
